12th Congress of the International Society of Nutrigenetics and Nutrigenomics

Winnipeg, MB ūüĆé September 30-October 3, 2018

Sunday, September 30, 2018

Session 1 ‚Äď Opening Ceremony and Plenary Lectures


Dr. Steven Zeisel

Dr. Steven Zeisel

Chapel Hill, North Carolina

Bio

Dr. Zeisel is the Kenan Distinguished University Professor in the Department of Nutrition in the Gillings School of Global Public Health and School of Medicine at the University of North Carolina at Chapel Hill. Dr. Zeisel earned his MD from Harvard Medical School in 1975, was a resident in pediatrics at Yale University from 1975‚Äď1977, and earned his PhD in nutrition at the Massachusetts Institute of Technology in 1980. He served as chair of the Department of Nutrition at UNC from 1990-2005.

Dr. Zeisel is the Director of the UNC Nutrition Research Institute and Director of the UNC Nutrition and Obesity Research Center (one of 12 centers of excellence funded by the US NIH), North Carolina. He serves on the Federation of American Societies for Experimental Biology (FASEB) Journal editorial board. His research team focuses on the essential nutrient choline and why there are individual differences in nutrient metabolism, using new approaches in nutrigenetics and metabolomics. Dr. Zeisel has proven that humans require choline and that this nutrient is critical for normal brain development, and for liver and muscle function. He is an international leader in the development of the field of precision nutrition. Based on his research, the US Institute of Medicine set a dietary requirement for choline in 1998. Dr. Zeisel has authored more than 350 scientific publications.

Dr. Laurette Dubé

Dr. Laurette Dubé

Professor, Marketing; James McGill Chair of Consumer and Lifestyle Psychology and Marketing; Chair and Scientific Director, McGill Centre for the Convergence of Health and Economics ‚Äď McGill University

Bio

Dr. Dubé is a Full Professor and holds the James McGill Chair of consumer and lifestyle psychology and marketing at the Desautels Faculty of Management of McGill University, Canada. Her research interest bears on the study of affects and behavioural economic processes underlying consumption and lifestyle behaviour and how such knowledge can inspire more effective health and marketing communications in both real-life and technology-supported media. She is the Founding Chair and Scientific Director of the McGill Centre for the Convergence of Health and Economics. The MCCHE was created to foster partnerships among scientists and decision-makers from all sectors of society to encourage a more ambitious notion of what can be done for more effective health management and novel pathways for social and business innovation.

Beyond books and scientific publications in the leading scientific journals of her field, including Journal of Consumer Research, Journal of Marketing Research, Journal of Marketing, Management Information System Quarterly and Journal of Personality and Social Psychology. Her transdiciplinary work has been presented in the Proceedings of the National Academy of Sciences and the Annals of the New York Academy of Sciences, her work has been covered in general audience and business publications such as Maclean’s, The Globe and Mail, USA Today, The Wall Street Journal, The Atlantic, and The Economist. Dr. Dubé received the YMCA Women of Distinction Award for the social sciences in 2011 and the Queen Elizabeth II Diamond Jubilee Medal in 2013. She is a Fellow of the Royal Society of Canada.

Sunday, September 30, 2018

Session 2 - Optimization of Food Quality Through Nutrigenomics: Canola


Dr. Robert Duncan

Dr. Robert Duncan

University of Manitoba

Bio

Robert Duncan is a canola and high erucic acid rapeseed breeder in the Department of Plant Science. Rob and his team develop new varieties that are grown by farmers across western Canada. His team focuses on developing high yielding, disease resistant varieties with excellent end use quality. End use quality includes the oil content, fatty acid profile, protein content and other protein-related traits. A major component of Rob’s research program is to increase the erucic acid content, which is used as a lubricant and slip agent and can be found in many household products (plastics and cosmetics) that are used on a daily basis. Rob’s team is also focused on characterizing the protein related-traits in Brassica species and determining the genetic control of these traits. Specific research goals include improving end use quality in these varieties in order to improve the extraction efficiency, as well as improving the agronomic traits so that farmers can grow their crop in a more economically and environmentally efficient manner.

Monday, October 1, 2018

Session 3 ‚Äď Optimization of Food Quality Through Nutrigenomics


Tom Warkentin;

Tom Warkentin

University of Saskatoon

Bio

Dr. Tom Warkentin is a Professor at the Crop Development Centre/Department of Plant Sciences, University of Saskatchewan. He received his Ph.D. in Crop Science from the University of Saskatchewan in 1992. He is breeding field pea cultivars with emphasis on agronomic traits (yield and lodging resistance), disease resistance (foliar and root diseases), and end-use quality (seed visual quality, seed coat durability, cooking quality, and nutritional quality including concentration of protein, starch, fiber, vitamins and minerals and their bioavailability). Tom is also involved in soybean breeding for the short season regions of western Canada with emphasis on high yield and early maturity.


David Mutch;

Dr. David Mutch

Guelph University

Bio

Dr. Mutch is an Associate Professor in the Department of Human Health & Nutritional Sciences at the University of Guelph, Canada. He received his Ph.D. from the University of Lausanne Switzerland, and completed post-doctoral fellowships at The Scripps Research Institute in San Diego and the French National Institute for Health and Medical Research in Paris. Dr. Mutch leads a nutrigenomics research program that explores how fatty acid-gene interactions contribute to the development of obesity-related complications. His research focuses on the critical role of fatty acid desaturase (FADS) genes in the synthesis of omega-3 and omega-6 fats, and their influence on metabolic health. Dr. Mutch also investigates if FADS genes can be used to personalize omega-3 dietary habits to improve an individual’s health and well-being. Dr. Mutch is Editor-in-Chief of Lifestyle Genomics, and has published over 80 peer-reviewed articles in the field of nutrigenomics.

Monday, October 1, 2018

Session 4 ‚Äď Epigenetics: The New Frontier in Personalization


Dr. Barbara Stefanska;

Dr. Barbara Stefanska, PhD, MPH

University of British Columbia

Bio

Dr. Barbara Stefanska is an Assistant Professor in Food, Nutrition and Health Program in the Faculty of Land and Food Systems at the University of British Columbia (UBC). She joined UBC in July 2017 from Purdue University, where she started her independent research path in nutritional sciences. Her area of expertise is nutritional epigenomics and cancer epigenetics. Dr. Stefanska completed a Master’s in public health and a PhD in biomedical sciences at Medical University of Lodz, Poland, followed by a postdoctoral training in the Department of Pharmacology and Therapeutics at McGill University in Montreal, Canada. During her doctoral and postdoctoral studies, Dr. Stefanska explored epigenetic effects of bioactive food components in cancer prevention and support of chemotherapy, and was the first who established the patterns of DNA methylation and gene expression in liver cancer patients and a functional role of DNA methylation differences observed between tumor and normal tissue. Her research determined a set of novel cancer candidate genes and potential diagnostic DNA methylation biomarkers. Epigenetic modifications play a significant role in normal development and genome stability and constitute a mechanism of genome adaptation to external stimuli.

Current research in Dr. Stefanska’s laboratory is focused on how diet can lead to health outcomes through modulating the epigenome and how the epigenome can serve as a readout of dietary exposures. Her research group investigates the link between bioactive food components, epigenetic alterations and carcinogenesis, including inflammation-driven cancer. A recent discovery by Stefanska’s group reports epigenetic mechanisms behind inhibition of the NOTCH oncogenic pathway in breast cancer upon exposure to polyphenols with stilbenoid structure. The results deliver a novel insight into epigenetic regulation of oncogenic signals in cancer and provide support for epigenetic-targeting strategies as an effective anticancer approach. Dr. Stefanska has published original research articles, reviews, commentaries, books and book chapters, and has given talks at national and international conferences. She serves on the editorial board of the British Journal of Pharmacology and is a member of the Prevention Group of the Alliance for Clinical Trials in Oncology.
http://www.landfood.ubc.ca/person/barbara-stefanska/


Dr. Luigi Bouchard

Dr. Luigi Bouchard

Université de Sherbrooke

Bio

Dr. Bouchard is associate professor of genetics and epigenetics at the Department of Biochemistry, Faculty of Medicine and Health Sciences, Université de Sherbrooke and head of the Department of Molecular Biology and Genetics at the university-affiliated Chicoutimi Hospital (QC, Canada). After Ph.D. studies in genetic epidemiology at Université Laval, he completed postdoctoral fellowships in transcriptomics (Dr. Marie-Claude Volh, CHU de Québec) and epigenomics (Dr. Arturas Petronis, University of Toronto). From 2008 to 2010, he was an Assistant Professor, Department of Medicine, Université de Montréal (QC, Canada).

Since 2009, he has been leading a research group dedicated to understand how epigenetic mechanisms are involved in the development of obesity, diabetes and cardiovascular disease. As a foundation of his research program, he contributed to build the ECO-21 and Gen3G Birth Cohorts, which included up to 1250 women recruited at the first trimester of pregnancy. The mothers and her child were then followed-up until 5 years postpartum. His current research projects aim to identify epigenetically-modified genes that play a causal role in fetal metabolic programming of childhood obesity as well as early epigenetic biomarkers for the development of gestational diabetes mellitus.


Dr. Vern Dolinsky

Dr. Vern Dolinsky

University of Manitoba

Bio

Vern Dolinsky is an Associate Professor at the University of Manitoba in the Department of Pharmacology and Research Scientist and Co-lead of the pediatric diabetes research theme (DREAM) at the Children’s Hospital Research Institute of Manitoba (CHRIM). He received his Master’s of Science at the University of Manitoba and his CIHR studentship-funded PhD at the University of Alberta. He completed post-doctoral fellowships at the University of Michigan and the University of Alberta.

Dr. Dolinsky’s research is focused on investigating the mechanisms involved in the development of gestational diabetes and how gestational diabetes contributes to the fetal programming of obesity, diabetes and related cardiovascular disorders in youth. His laboratory utilizes a combination of experimental animals, in vivo imaging as well as cellular molecular, biochemical, genomic and epigenomic approaches to expand the knowledge about the biological mechanisms that lead to obesity, diabetes and heart disease. This information aims to guide the development of novel therapies for obesity, diabetes and heart disease. Dr. Dolinsky’s lab is currently funded by two grants from the CIHR, the Heart and Stroke Foundation of Canada, Research Manitoba and the Canadian Foundation for Innovation. Dr. Dolinsky was recently awarded the Stewart Whitman-Amgen, the Ken Hughes Young Investigator Awards, Dr. John Moorhouse Research Fellow of the Diabetes Foundation of Manitoba and he is currently the Allen Rouse Basic Scientist of the Manitoba Medical Services Foundation.

Monday, October 1, 2018

Session 5 ‚Äď Genetic and Lifestyle Factors for Chronic Societal Diseases: Implications for Preventive Personalized Medicine


peter_karl;

Dr Peter Eck

University of Manitoba

Bio

Dr. Peter Eck, Associate Professor, Department of Human Nutritional Sciences at the University of Manitoba, investigates the impacts of genetic variations on health outcomes which are modifiable by lifestyle interventions. He discovered novel vitamin C transporters and associated their genetic variations with a variety of common and complex diseases. He also associated variations in various other nutrient membrane transporter genes with Inflammatory Bowel Diseases. He investigates the biological impact of disease associated genetic variations using molecular biology, cell biology and model organisms. Dr. Eck’s research aims to contribute to the development of personalized lifestyle interventions based on an individual’s genetic background.


Louis Pérusse;

Louis Pérusse

Université Laval

Bio

Dr. Louis Pérusse is Professor and director of the Department of Kinesiology at the Faculty of Medicine in Laval University, Québec. He is a genetic epidemiologist with more than 20 years of research experience in the field of the genetics of complex diseases such as obesity, diabetes and cardiovascular diseases. Dr Pérusse is a member of the Institute of Nutraceutical and Functional Foods (INAF) of Laval University and past Editor-in-Chief of the Journal of Nutrigenetics and Nutrigenomics. He is the author of more than 500 papers and communications in the field of genetics of obesity and its related-metabolic complications and of adaptation to exercise training.


Marie-Claude Vohl;

Marie-Claude Vohl

Université Laval

Bio

Marie-Claude Vohl completed her graduate studies at Laval University (1992-1997). She was interested in the genetics of dyslipidemia and obesity-related metabolic complications. In 1997-1998, she was enrolled in a post-doctoral fellow at the University of Ottawa Heart Institute where she studied antioxidant properties of HDL particles. During her second post-doctoral training (1998-1999) at McGill University in Montreal, she was interested in the genetics of complex diseases. She was appointed as a professor at the Department of Food Science and Nutrition at Laval University (Québec City) in 1999. Her research projects are aimed at the genetic/epigenetic dissection of the obesity-related metabolic complications. She is also interested in nutrigenetics/nutrigenomics and conducted different cross-sectional and clinical trials examining the combined effects of fish nutrients and genetic factors on cardiometabolic risk factors.

Since the beginning of her career, Professor Marie-Claude Vohl has published more than 240 peer-reviewed papers. She has been invited to give several presentations in national and international conferences. Her research programs are funded among others by CIHR, HSFC and NSERC. Since 2010, she is Canada Research Chair Tier 1 in Genomics Applied to Nutrition and Metabolic Health.


Olivia Dong;

Olivia Dong

Center of Precision Medicine ‚Äď North Carolina

Bio

Olivia Dong is a registered dietitian, a licensed dietitian nutritionist in the state of North Carolina, and is currently a PhD candidate in the Center for Pharmacogenomics and Individualized Therapy at the UNC Eshelman School of Pharmacy. Her dissertation research focuses on the development of a new pharmacogenetic test, DNA2RxTM, which uses targeted next-generation sequencing technology, and she is studying the pharmacoeconomic benefits of implementing this test for patients with coronary artery disease to help inform insurance reimbursement policies. In addition, Olivia is integrating her training in nutrition and pharmaceutical sciences to develop the pharmaconutrigenetics field within precision medicine and has been invited to speak on this topic for various professional health groups in North Carolina.

Olivia is a board member for the Durham-Chapel Hill Dietetic Association in North Carolina and serves as a nutritional biochemistry/genomics co-editor for the Dietitians in Functional Medicine Practice Group for the Academy of Nutrition and Dietetics. Olivia has received the Emerging Dietetic Leader Award from the Durham-Chapel Hill Dietetic Association and the Recognized Young Dietitian of the Year Award from the North Carolina Academy of Nutrition and Dietetics. She is a P.E.O Scholar and was the recent recipient of the Kathryne A. Brewington Graduate Student Research Award, which is given annually to the most outstanding doctoral student in the UNC Eshelman School of Pharmacy. Olivia completed her MPH from the UNC Gillings School of Global Public Health, her dietetics training from UNC Medical Center, and her BS in nutritional sciences, dietetics from UC Berkeley.

Monday, October 1, 2018

Session 6 - From Genetics to Public Health


Jose Ordova;

José Ordová

Tufts University

Bio

José M. Ordovás is Professor of Nutrition and Genetics at Tufts University and Senior Scientist at the USDA-Human Nutrition Research Center on Aging in Boston, where he also is the Director of the Nutrition and Genomics Laboratory. He is a Senior Scientist at IMDEA Alimentacion (Madrid, Spain). Dr. Ordovas was educated in Spain at the University of Zaragoza where he completed his undergraduate work in chemistry and received his PHD. He did postdoctoral work at MIT, and Harvard.

Dr. Ordovas’ research focuses on the genetic/epigenetic factors predisposing to cardiovascular disease and obesity and their interaction with the environment and behavioral factors with emphasis on diet. He has published about 800 scientific articles in peer review journals.

Throughout his career, Dr. Ordovas has received multiple honors for his scientific achievements including the USDA Secretary’s Award, the Danone Foundation Award, and the honorary degree in Medicine by the University of Cordoba in Spain. He is a Member of the Spanish Royal Academies of Sciences, Medicine, Nutrition and Pharmacy.

He serves on multiple editorial, advisory and peer review committees and he is a member of the Comité Científico y Técnico de la Agencia Estatal de Investigación (AEI) in Spain.

Tuesday October 2, 2018

Session 7 ‚Äď Nutrigenetics and the Microbiome

TBA

Tuesday October 2, 2018

Session 8 ‚Äď Integrative ‚ÄėOmics for Personalized Health


Dr. Wenyu-Zhou;

Dr. Wenyu-Zhou

Stanford University

Bio

Dr. Zhou received her PhD in Biology from University of Washington at Seattle in 2012. She recently finished her post-doctorate training with Dr. Michael Snyder at Stanford University. With Dr. Snyder, she studies Type 2 Diabetes (T2D), and utilizes multi-omic techniques to measure both host and microbial molecular changes over time and to understand underlying associations with the disease onset and development. Recently, Zhou and others published a controlled longitudinal weight perturbation study with intensive characterizations by multi-omics profiling to further understand the insulin resistance, which is an important factor in T2D development. Zhou has published papers in internationally reputable journals, such as Nature Biotechnology, Cell Stem Cell, Cell Systems, EMBO Journal and PNAS, and actively serves as a reviewer for a number of scientific journals in the genomics field.


Olievr Fiehn;

Prof. Oliver Fiehn

University of California Davis, NIH West Coast Metabolomics Center

Bio

Prof. Oliver Fiehn has pioneered developments and applications in metabolomics with over 220 publications to date, starting in 1998 as postdoctoral scholar and from 2000 onwards as group leader at the Max-Planck Institute for Molecular Plant Physiology in Potsdam, Germany. Since 2004 he is Professor at the UC Davis Genome Center, overseeing his research laboratory and the satellite core service laboratory in metabolomics research. Since 2012, he serves as Director of the NIH West Coast Metabolomics Center, supervising 35 staff operating 16 mass spectrometers and coordinating activities with three UC Davis satellite labs, including efforts for combined interpretation of genomics and metabolomics data. The West Coast Metabolomics Center provides the most extensive and most in-depth analysis of metabolites available today, using a range of validated protocols for fee-for-service projects and scientific collaborations.

Professor Fiehn’s research aims at understanding metabolism on a comprehensive level in human population cohorts, animal and plant models, and cells and microorganisms. In order to leverage data from these diverse sets of biological systems, his research laboratory focuses on standardizing metabolomic reports and establishing metabolomic databases and libraries, for example the MassBank of North America that hosts over 200,000 public metabolite mass spectra and BinBase, a resource of over 90,000 samples covering more than 1,900 studies. Professor Fiehn’s laboratory members develop and implement new approaches and technologies in analytical chemistry for covering the metabolome, from increasing peak capacity by ion mobility to compound identifications through cheminformatics workflows and software. He collaborates with a range of investigators for interpreting metabolomic data in human diseases through statistics, text mining and pathway-based mapping efforts. He also studies fundamental biochemical questions from metabolite damage repair to the new concept of epimetabolites, the chemical transformation of primary metabolites that gain regulatory functions in cells.

For his work, Professor Fiehn has received a range of awards including the 2014 Molecular & Cellular Proteomics Lecture Award and the 2014 Metabolomics Society Lifetime Achievement Award. He served on the Board of Directors of the Metabolomics Society from 2005-2010 and 2012-2015, organizing a range of workshops and conferences, including the 2011 Asilomar metabolomics meeting and the 2015 Metabolomics Society international conference in San Francisco that reached a record of over 1,000 participants.


martin_kohlmeier;

Martin Kohlmeier

University of North Carolina, NIH West Coast Metabolomics Center

Bio

Martin Kohlmeier, MD, PhD, after medical school and residency training, completed graduate studies in bioinformatics, clinical chemistry and laboratory medicine at Heidelberg University, at the Max-Planck-Institute for Nutrition Research in Dortmund, and later at the Free University in Berlin. He is professor of nutrition at the University of North Carolina at Chapel Hill, director of the Human Research Core and the nutrigenetics laboratory at the UNC Nutrition Research Institute in Kannapolis, fellow of Wolfson College at Cambridge University, UK, and president-elect of ISNN.

He investigates what inherited differences mean for nutrient metabolism and how genetic information can support better nutrition decisions. For translation of such insights into practice he has developed software that guides towards food choices tailored to individual needs and preferences (https://www.nutriscope.us, access code ‚Äúin18‚ÄĚ).

Current work focuses on precision nutrition for improving muscle performance, nutrient-gene interactions causing muscle loss with advancing age, and genetic variants responsible for differences in energy metabolism.

Tuesday October 2, 2018

Session 9 ‚Äď Human Behavior: The Bottleneck between Nutrigenetics, Nutrigenomics and their Personal and Public Health Impact


Ahmed_El-Sohemy;

Dr. Ahmed El-Sohemy

University of Toronto

Bio

Dr. Ahmed El-Sohemy is a Full Professor at the University of Toronto and has held a Canada Research Chair in Nutrigenomics. He earned his PhD in Nutritional Sciences from the University of Toronto and completed a postdoctoral fellowship at Harvard. He returned to Toronto in 2000 to establish a research program in nutritional genomics. The goal of his research is to elucidate the genetic basis for variability in nutrient response on health and performance. Dr. El-Sohemy has published over 140 peer-reviewed articles and has given over 200 invited talks around the world. He is on the editorial board of 10 scientific and medical journals and served as an expert reviewer for more than 30 other journals and 12 granting agencies. He has over 5,300 citations with an H-index of 41. Dr. El-Sohemy has served on Health Canada’s Scientific Advisory Board and several international expert advisory panels. He has made numerous appearances on TV, radio and in print media, and was voted one of the top 10 people to watch in 2004 by the Toronto Star, Canada’s largest daily newspaper, and in 2007 was nominated for Canada’s Top 40 Under 40 award. In 2013, Dr. El-Sohemy was named one of the top 10 inventors of the year by UofT and the following year he was awarded the Centrum Foundation New Scientist Award for Outstanding Research by the Canadian Nutrition Society. Last year he was awarded the Mark Bieber Professional Award by the American College of Nutrition. He is the founder of Nutrigenomix Inc. and Chair’s the company’s International Science Advisory Board.


Susan Carnell;

Susan Carnell,

John Hopkins University

Bio

Susan Carnell received her BA in Experimental Psychology from the University of Oxford and her PhD in Health Psychology at University College London, and completed post-doctoral training at University College London and Columbia University. In 2013 she joined the Division of Child & Adolescent Psychiatry, Department of Psychiatry & Behavioral Sciences, Johns Hopkins School of Medicine, where she is an Assistant Professor. The central question motivating her research program is, "Why do some people become obese while others don't?‚ÄĚ To address this she uses a range of methods including behavioral tests, self- and parent-report questionnaires, genotyping, hormonal assays, and neuroimaging techniques (fMRI, MRI, PET). Ongoing research projects include investigations of appetite and body weight in infants, children, adolescents and adults, including studies of bariatric surgery and anorexia nervosa.


Charles Spence;

Charles Spence

Oxford University

Bio

Professor Charles Spence is a world-famous experimental psychologist with a specialization in neuroscience-inspired multisensory design. He has worked with many of the world‚Äôs largest companies across the globe since establishing the Crossmodal Research Laboratory (CRL) at the Department of Experimental Psychology, Oxford University in 1997. Prof. Spence has published over 800 articles and edited or authored, 10 academic volumes including, in 2014, the Prose prize-winning ‚ÄúThe perfect meal‚ÄĚ, and the recent bestseller ‚ÄúGastrophysics: The new science of eating‚ÄĚ (2017; Penguin Viking). Much of Prof. Spence‚Äôs work focuses on the design of enhanced multisensory food and drink experiences, through collaborations with chefs, baristas, mixologists, perfumiers, and the food and beverage, and flavour and fragrance industries. Prof. Spence has also worked extensively on the question of how technology will transform our dining experiences in the future.

Tuesday October 2, 2018

Session 10 ‚Äď Debate Forum ‚Äď Are we ready for personalized nutrition?



Dr. Dylan MacKay

Dr. Dylan MacKay

University of Manitoba

Bio

Dr. MacKay has a PhD in Human Nutritional Sciences and is an Assistant Professor in the Department of Community Health Sciences at the University of Manitoba. He is also a Clinical Trialist at the George and Fay Yee Centre for Healthcare Innovation. Dylan is a nutritional biochemist, specializing in human clinical trials and inter-individual variability. Dylan is also very interested in how to appropriately translate scientific findings to combat misinformation, especially on the internet and social media. Twitter: @dylanmackayphd


Ahmed_El-Sohemy;

Dr. Ahmed El-Sohemy

University of Toronto

Bio

Dr. Ahmed El-Sohemy is a Full Professor at the University of Toronto and has held a Canada Research Chair in Nutrigenomics. He earned his PhD in Nutritional Sciences from the University of Toronto and completed a postdoctoral fellowship at Harvard. He returned to Toronto in 2000 to establish a research program in nutritional genomics. The goal of his research is to elucidate the genetic basis for variability in nutrient response on health and performance. Dr. El-Sohemy has published over 140 peer-reviewed articles and has given over 200 invited talks around the world. He is on the editorial board of 10 scientific and medical journals and served as an expert reviewer for more than 30 other journals and 12 granting agencies. He has over 5,300 citations with an H-index of 41. Dr. El-Sohemy has served on Health Canada’s Scientific Advisory Board and several international expert advisory panels. He has made numerous appearances on TV, radio and in print media, and was voted one of the top 10 people to watch in 2004 by the Toronto Star, Canada’s largest daily newspaper, and in 2007 was nominated for Canada’s Top 40 Under 40 award. In 2013, Dr. El-Sohemy was named one of the top 10 inventors of the year by UofT and the following year he was awarded the Centrum Foundation New Scientist Award for Outstanding Research by the Canadian Nutrition Society. Last year he was awarded the Mark Bieber Professional Award by the American College of Nutrition. He is the founder of Nutrigenomix Inc. and Chair’s the company’s International Science Advisory Board.